Metronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential

Acta Paediatrica
Mikaela PorkholmSanna-Maria Kivivuori

Abstract

Children with refractory or high-risk malignancies frequently suffer from poor quality of life during palliative care. This study explored the effect of metronomic drug administration on survival and quality of life in paediatric patients with various refractory or high-risk tumours. We treated 17 patients with a maintenance therapy that consisted of metronomic thalidomide, etoposide and celecoxib. The endpoints of the study were overall and progression-free survival, changes in the Karnofsky-Lansky scores from baseline to the end of the study therapy and radiological responses. The median overall survival after the start of the study therapy was 6.2 months (range 2.0-57.7), and the six-, 12- and 24-month survival rates were 59%, 18% and 18%, respectively. The median progression-free survival was 3.2 months (range 0.3-17.8). The Karnofsky-Lansky scores increased significantly during the study therapy (p = 0.02), with 35% of the patients having a transient improvement in their clinical status. Radiologically, one partial response and two disease stabilisations were encountered. Grade III-V adverse events occurred in 76% of the patients. Metronomic therapy may increase the quality of life during palliative care for childhood canc...Continue Reading

References

May 31, 2002·Journal of Pediatric Surgery·Kimberly W McCruddenWilliam Middlesworth
Jun 3, 2004·Lancet·Michael E FranksWilliam D Figg
Nov 12, 2005·Journal of Pediatric Hematology/oncology·Mark W KieranJudah Folkman
Sep 15, 2006·Pediatric Blood & Cancer·J M J TheunissenC H M van den Ende
Nov 8, 2008·Pediatric Blood & Cancer·Andrea D OrseyChris Feudtner
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
May 15, 2009·Pediatric Blood & Cancer·Angélique RomeEddy Pasquier
Feb 27, 2010·Critical Reviews in Oncology/hematology·Catherine TerretJean Pierre Droz
Nov 26, 2010·Pediatric Blood & Cancer·Jane E MinturnJean B Belasco
Dec 18, 2010·Journal of Pediatric Hematology/oncology·Traore FousseyniNicolas André
Jul 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sushil KumarSylvain Baruchel
Dec 8, 2011·Pediatric Blood & Cancer·Andreas PeyrlIrene Slavc
Dec 14, 2011·Oncotarget·Nicolas AndréArnauld Verschuur
Jun 11, 2014·Nature Reviews. Clinical Oncology·Nicolas AndréEddy Pasquier

❮ Previous
Next ❯

Citations

Mar 29, 2019·Pediatric Blood & Cancer·Marie-Amélie Heng-MaillardNicolas André
Jul 2, 2020·OncoTargets and Therapy·Deepam PushpamBivas Biswas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.